Rite Aid Corp (NYSE:RAD)

CAPS Rating: 3 out of 5

The Company is a Delaware corporation and through its wholly-owned subsidiaries, operates retail drugstores in the United States of America.

Results 1 - 20 of 244 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar FullerAMB (64.37) Submitted: 5/4/2015 2:43:44 PM : Outperform Start Price: $8.14 RAD Score: -0.92

Don't really like it at $8 but long term so will be okay if it comes in a bit.

Recs

0
Member Avatar peteypab (< 20) Submitted: 4/24/2015 12:34:42 PM : Outperform Start Price: $8.28 RAD Score: -2.51

buyout/obamacare

Recs

0
Member Avatar ltfaaith (< 20) Submitted: 4/19/2015 5:09:18 PM : Outperform Start Price: $8.09 RAD Score: -1.54

They are making smart financial decisions. They get a big tax break for buying.. Rite Aid will acquire EnvisionRx, a portfolio company of leading global private investment firm TPG, in a transaction valued at approximately $2 billion, which includes the value of an expected future tax benefit of $275 million

Recs

0
Member Avatar Jaybird49 (74.09) Submitted: 4/9/2015 5:00:59 PM : Outperform Start Price: $8.31 RAD Score: -4.08

One thing that's sometimes missed here is their miraculous recovery over the last 15 years. And how well they have managed their crushing debt burden.

Recs

0
Member Avatar ariskmgr (< 20) Submitted: 3/21/2015 4:37:27 PM : Outperform Start Price: $8.11 RAD Score: -1.14

Sure it has big debt. But the resulting earnings from the recent buys will set it up to be a major player in health services.

Recs

0
Member Avatar rooberto (< 20) Submitted: 2/25/2015 8:07:31 PM : Outperform Start Price: $8.15 RAD Score: -1.11

Solid business model. Will slowly chip away at Walgreens and cvs. Will double in 5 years.

Recs

0
Member Avatar john603 (56.08) Submitted: 1/29/2015 5:18:42 PM : Outperform Start Price: $7.20 RAD Score: +6.38

Like the company. Good prices and service. Cred Swiss rates it an outperform. It is going to be a bad flue season.

Recs

0
Member Avatar Kidkerner (38.30) Submitted: 1/19/2015 8:42:48 AM : Outperform Start Price: $7.48 RAD Score: +3.19

Fought to stay relevant, now focused on growth through prescription drug sales.

Recs

0
Member Avatar txconrad (< 20) Submitted: 1/6/2015 3:44:37 PM : Outperform Start Price: $7.65 RAD Score: -0.17

one of the big three drug stores. finally learning from CVS & Walgreens on how to operate.Revenue per employee is approx. 1/3 that of CVS.

Recs

0
Member Avatar Johnnkay1000 (< 20) Submitted: 11/5/2014 8:43:45 PM : Outperform Start Price: $5.20 RAD Score: +49.81

Pure growth....aging populace

Recs

0
Member Avatar youngblood58 (29.26) Submitted: 11/5/2014 9:11:39 AM : Outperform Start Price: $5.33 RAD Score: +46.19

I like the McKesson distribution deal, and I think after a significant pull back, it's time to get back into RAD. They keep showing sales increases, and I look for that to continue through the holiday season. In the short term, the Apple Pay brouhaha is meaningless. We'll see about that longer term.

Recs

0
Member Avatar asilverp (60.96) Submitted: 8/29/2014 10:31:47 PM : Outperform Start Price: $6.21 RAD Score: +24.20

Low P/S, Momentum.

Recs

0
Member Avatar Toady (< 20) Submitted: 8/10/2014 11:34:59 PM : Outperform Start Price: $6.13 RAD Score: +22.12

1. Wellness+ program rewards people and keeps them coming back.
2. "According to the U.S. Census Bureau, there are more than 77 million boomers in the U.S. and by 2030, this demographic (born between 1946 and 1964) will represent an estimated 20% of the population. This means more than 10,000 baby boomers will turn 65 every day for the next 19 years." Look for an influx of 65+ aged retirees needing prescription. Check out their Wellness65+ program.
3. Affordable Healthcare Act. + Generic Drugs + McKesson deal = great long term growth opportunity.
4. Redoing a lot of run down stores.
5. New stores look amazing. The one down my street is new and looks clean and fresh. The customer service is very good too.

Recs

0
Member Avatar TheManTheMyth (20.85) Submitted: 7/29/2014 10:56:55 AM : Outperform Start Price: $6.54 RAD Score: +16.22

sell off currently has the rsi in oversold territory, conservative guidance coupled with high consumer confidence makes for beating street expectations probable.

if you're looking for a time to buy, now might be your chance... but what do i know

Recs

0
Member Avatar Maotennessee (< 20) Submitted: 7/16/2014 4:28:24 PM : Outperform Start Price: $7.06 RAD Score: +6.88

Turning around a sinking company with hard numbers is quite amazing. I'd hold but not invest until it show a turn around, I'm looking at 7.75 to 8 before getting in.

Recs

0
Member Avatar drummergolfer (< 20) Submitted: 7/14/2014 7:33:13 PM : Outperform Start Price: $7.21 RAD Score: +4.73

I invested in RAD last summer and sold when I was up 125%. Saw another move coming which didn't really materialize this year, but still holding on up about 7%.Oh well!

Recs

0
Member Avatar TMFbelle (53.14) Submitted: 6/30/2014 9:09:41 AM : Outperform Start Price: $7.18 RAD Score: +4.10

Good example of a turn-around story. RAD has been striving to recuperate their brand as well as their previous strong positioning within the pharmacy/health care industry. Despite some struggles and competition, I feel the company is making sound strategic investments that should result in long term positive results. From retail clinics to new "wellness" focused stores, among other up and coming initiatives I can see the company achieving full success in the coming years.

Recs

0
Member Avatar loalgee (< 20) Submitted: 6/26/2014 10:24:43 AM : Outperform Start Price: $7.26 RAD Score: +2.34

Rad has a sound strategy with great looking store remodels and it's wellness focused marketing strategy.

Recs

0
Member Avatar breretonlake (< 20) Submitted: 6/7/2014 9:40:01 AM : Outperform Start Price: $7.71 RAD Score: -3.71

Compared to its competition like Walgreen, this stock is priced right and is set to go up.

Recs

0
Member Avatar bemely (< 20) Submitted: 4/17/2014 2:39:47 PM : Outperform Start Price: $7.30 RAD Score: -2.81

Rite Aid is a turn around situation that is realistic and is happening.

Featured Broker Partners


Advertisement